Financing channel feed – Endpoints News

Financing channel feed

In aiming to bypass CRISPR's delivery issues, one startup eyes the gene editing Spotlight

4 years ago

In year 3 of the pandemic, a new Covid-19 biotech takes flight with an antibody combo and Takeda's ex-vaccines chief at the helm

4 years ago

A new cell therapy startup from an immunotherapy pioneer raises $175M in KRAS quest

4 years ago

Going...going...gone. A small biotech throws in its IPO cards after market meltdown

4 years ago

Biotech upstart rides the upsurge in radiopharma R&D to $88M round with marquee investors

4 years ago

With its share price chewed to pieces, Nick Leschly's 2seventy scores $170M to help weather the storm

4 years ago

Back to the fundamentals: Frazier rolls out $1B fund to ramp up a new slate of biotech startups

4 years ago

Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic

4 years ago

Morningside reveals its latest biotech effort, seeking to tackle wide range of inflammatory diseases

4 years ago

Blackstone leads $200M injection into data analysis software maker

4 years ago

Kurma scores $175M in first closing of biotech/healthtech fund — the VC's largest yet

4 years ago

Sherlock, Feng Zhang's CRISPR diagnostic outfit, grabs $80M to go beyond Covid-19

4 years ago

With investment from Alloy, Boston peptide manufacturer announces Series A

4 years ago

An AI biotech emerges from stealth promising drugs 'on demand.' What will that look like, and is it even possible?

4 years ago

Looking to push checkpoint efficacy, a quiet microbiome upstart bags $67M for clinical work

4 years ago

A lone biotech braves the bone-dry IPO forecast, seeking to go public amidst a barren landscape

4 years ago

UK to invest $345M to bolster life science research, manufacturing capabilities

4 years ago

A dynamic oncology duo team up on an I/O startup focused on next-gen solid tumor fighters

4 years ago

A new biotech out of Dana-Farber wants to join the long non-coding RNA party, with help from Bob Langer

4 years ago

Precision immunology player bags $110M to fund its work on 'disease signature' tests

4 years ago

With a new startup, ARCH and Takeda wade into growing search for a Swiss Army knife RNA drug

4 years ago

Akebia scrapes together $85M war chest to commercialize vada as PDUFA date looms

4 years ago

SoftBank, RA keep pumping money into biotech startups as protein degradation player bags $102M

4 years ago

They made the first anti-VEGF drug 20+ years ago. Now two longtime partners have $65M to spot new eye drugs

4 years ago

First page Previous page 57 58 596061 62 63 Next page Last page